5-{3-[4-(3-chlorophenyl)hexahydro-1-pyrazinyl]propyl}-3-methyl-7-phenyl-4,5-dihydroisoxazolo[4,5-d]pyridazin-4-one

ID: ALA10161

Chembl Id: CHEMBL10161

PubChem CID: 11754159

Max Phase: Preclinical

Molecular Formula: C25H26ClN5O2

Molecular Weight: 463.97

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1noc2c(-c3ccccc3)nn(CCCN3CCN(c4cccc(Cl)c4)CC3)c(=O)c12

Standard InChI:  InChI=1S/C25H26ClN5O2/c1-18-22-24(33-28-18)23(19-7-3-2-4-8-19)27-31(25(22)32)12-6-11-29-13-15-30(16-14-29)21-10-5-9-20(26)17-21/h2-5,7-10,17H,6,11-16H2,1H3

Standard InChI Key:  NKYYDZOPTBYOLZ-UHFFFAOYSA-N

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra2a Alpha-2a adrenergic receptor (204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cerebral cortex (17 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a2 Norepinephrine transporter (2222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 463.97Molecular Weight (Monoisotopic): 463.1775AlogP: 4.23#Rotatable Bonds: 6
Polar Surface Area: 67.40Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.58CX LogP: 3.80CX LogD: 3.40
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.43Np Likeness Score: -1.85

References

1. Giovannoni MP, Vergelli C, Ghelardini C, Galeotti N, Bartolini A, Dal Piaz V..  (2003)  [(3-Chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents.,  46  (6): [PMID:12620082] [10.1021/jm021057u]
2. Cesari N, Biancalani C, Vergelli C, Dal Piaz V, Graziano A, Biagini P, Ghelardini C, Galeotti N, Giovannoni MP..  (2006)  Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action.,  49  (26): [PMID:17181165] [10.1021/jm060743g]

Source